Biologic
therapeutics include virus, therapeutic serum, toxin, allergenic product,
antitoxin, blood component or derivative, vaccine, blood, protein (except any
chemically synthesized polypeptide), or analogous product, or arsphenamine or
derivative of arsphenamine (or any other trivalent organic arsenic compound),
intended for the prevention, treatment, or cure of a disease or condition.
These products differ from small molecules in terms of molecular weight,
structure, synthesis, and immunogenicity. Biologic products are generally characterized
by high molecular weight and complex structures. These products are usually
derived from living entities and are less easily characterized compared to
small molecules. These products are often susceptible to extreme temperatures
and light.
Analysts forecast
the Global Biologic
Therapeutics market to grow at
a CAGR of 8.22 percent over the period 2013-2018.
The report recognizes
the following companies as the key players in the Global Biologic Therapeutics
Market: Amgen Inc., F. Hoffmann-La Roche Ltd., Novo Nordisk A/S and Sanofi SA.
Other Prominent
Vendors in the market are: Abbvie, AstraZeneca, Bavarian Nordic, Baxter
International, Beijing Minhai Biotechnology, Bharat Biotech, Bharat
Immunologicals and Biologicals, bioCSL, Biodel, Bio Med, Bristol-Myers Squibb,
Diamyd Medical, DiaVacs, Dynavax Technologies, Eli Lilly, Generex
Biotechnology, Hualan Biological Engineering, Imunoloski Zavod, Indian Immunologicals,
Janssen Pharmaceuticals, JN International Medical, Kaketsuken, LG Life
Sciences, Macrogenics, MannKind, Merck, Mitsubishi Tanabe Pharma, Nuron
Biotech, Osiris Therapeutics, Pfizer, Protalix, Protein Sciences, Serum
Institute of India, Shenzhen Kangtai Biological Products, Sinovac Biotech,
Tolerion, Vacunas Finlay, XOMA and Zydus Cadila.
One key trend
upcoming in this market is the emergence of targeted therapies, which are
generally associated with better efficacy and safety compared to traditional
drugs. Thus, these drugs are expected to increase patient compliance and fuel
the market.
Get discount on the
Report @ http://www.sandlerresearch.org/discount?rname=26232
.
Covered in this Report
This report covers
the present scenario and the growth prospects of the Global Biologic
Therapeutics market for the period 2014-2018. To calculate the market size, the
report considers revenue generated through the sales of the following drugs:
- Protein therapeutics (monoclonal antibodies, enzymes, and other protein therapeutics)
- Vaccines (pediatric vaccines and adult vaccines)
- Cell therapy
The Other Protein
Therapeutics segment covers proteins such as cytokines, fusion proteins,
peptide antibiotics, peptide hormones, and blood factors.
Global Biologic
Therapeutics Market 2014-2018, has been prepared based on an in-depth market
analysis with inputs from industry experts. The report covers the Americas, and
the EMEA and APAC regions; it also covers the Global Biologic Therapeutics
market landscape and its growth prospects in the coming years. The report also
includes a discussion of the key vendors operating in this market.
According to the
report, an aging population is one of the major drivers of the market. An
increase in the aging population is expected to increase the population of
patients suffering from a variety of diseases, and thereby drive the market.
Further, the report
states that the need for cold storage is one of the major challenges in the
market. Cold storage increases the transportation and storage costs of the
therapeutic products, thereby adding to the final cost of the products.
Single User License
of the Report is Available at USD 3500, Buy the Report @ http://www.sandlerresearch.org/purchase?rname=26232
.
